Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England

BACKGROUND: England's National Institute for Health and Care Excellence (NICE) and the US’ Institute for Clinical and Economic Review (ICER) both conduct cost-effectiveness evaluations for new cancer drugs to help payers make drug coverage decisions. However, NICE and ICER assessments have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherla, Avi, Renwick, Matthew, Jha, Ashish, Mossialos, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788430/
https://www.ncbi.nlm.nih.gov/pubmed/33437948
http://dx.doi.org/10.1016/j.eclinm.2020.100625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788430/
https://www.ncbi.nlm.nih.gov/pubmed/33437948
http://dx.doi.org/10.1016/j.eclinm.2020.100625

Ejemplares similares